1. Home
  2. ALNY
  3. ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on July 8, 2025

Exploring Three High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

11 days ago

Exploring Three High Growth Tech Stocks In The US Market

Exploring 3 High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

11 days ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

12 days ago

Exploring High Growth Tech Stocks In The US Market

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?
ALNY

Simply Wall St.

12 days ago

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Exploring Three High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

12 days ago

Exploring Three High Growth Tech Stocks in the US Market

Exploring US High Growth Tech Stocks For Potential Opportunities
ALNY

Simply Wall St.

13 days ago

Exploring US High Growth Tech Stocks For Potential Opportunities

US High Growth Tech Stocks To Watch In June 2025
ALNY

Simply Wall St.

13 days ago

US High Growth Tech Stocks To Watch In June 2025

High Growth Tech Stocks To Watch In US June 2025
ALNY

Simply Wall St.

14 days ago

High Growth Tech Stocks To Watch In US June 2025

Exploring US High Growth Tech Stocks To Watch In June 2025
ALNY

Simply Wall St.

14 days ago

Exploring US High Growth Tech Stocks To Watch In June 2025

Exploring 3 High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

15 days ago

Exploring 3 High Growth Tech Stocks In The US Market

High Growth Tech Stocks in US for June 2025
ALNY

Simply Wall St.

15 days ago

High Growth Tech Stocks in US for June 2025

Exploring 3 High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

18 days ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring Three High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

19 days ago

Exploring Three High Growth Tech Stocks In The US Market

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase
ALNY

Simply Wall St.

19 days ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Alnylam names Pushkal Garg as EVP, chief research and development officer
ALNY

TipRanks

19 days ago

Alnylam names Pushkal Garg as EVP, chief research and development officer

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer
ALNY

Business Wire

20 days ago

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Exploring High Growth Tech Opportunities in US Markets
ALNY

Simply Wall St.

21 days ago

Exploring High Growth Tech Opportunities in US Markets

Exploring High Growth Tech Stocks In The US This June 2025
ALNY

Simply Wall St.

22 days ago

Exploring High Growth Tech Stocks In The US This June 2025

The European Commission Approves Alnylam’s AMVUTTRA
ALNY

Insider Monkey

a month ago

The European Commission Approves Alnylam’s AMVUTTRA

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
ALNY

GlobeNewswire

a month ago

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM
ALNY

Zacks

a month ago

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM

EC approves Alnylam’s vutrisiran for ATTR-CM treatment
ALNY

Pharmaceutical Technology

a month ago

EC approves Alnylam’s vutrisiran for ATTR-CM treatment

ALNY

MT Newswires

a month ago

Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

a month ago

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?
ALNY

Zacks

a month ago

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?

This week in Trumponomics: Too bad TACO isn’t true
ALNY

Yahoo Finance

a month ago

This week in Trumponomics: Too bad TACO isn’t true

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
ALNY

Yahoo Finance Video

a month ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Ford recalls more than 29,000 vehicles in the US, NHTSA says
ALNY

Reuters

a month ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states
ALNY

USA TODAY

a month ago

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

Saturday Sessions: OK Go performs "Love"
ALNY

CBS News Videos

a month ago

Saturday Sessions: OK Go performs "Love"

Behind the scenes of an OK Go music video
ALNY

CBS News Videos

a month ago

Behind the scenes of an OK Go music video

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital
ALNY

Simply Wall St.

a month ago

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back
ALNY

Investor's Business Daily

a month ago

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference
ALNY

Business Wire

a month ago

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference

3 High-Flying Stocks That Could Soar Even More
ALNY

Motley Fool

a month ago

3 High-Flying Stocks That Could Soar Even More

Alnylam Issues 2024 Corporate Responsibility Report
ALNY

Business Wire

2 months ago

Alnylam Issues 2024 Corporate Responsibility Report

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,124,217, According to a Recent SEC Filing

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B
ALNY

Business Wire

2 months ago

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

High Growth US Tech Stocks To Watch In May 2025
ALNY

Simply Wall St.

2 months ago

High Growth US Tech Stocks To Watch In May 2025

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term
ALNY

Insider Monkey

2 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability

ALNY

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Vir Biotechnology Inc Earnings Call

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
ALNY

Simply Wall St.

2 months ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications
ALNY

Pharma Voice

2 months ago

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
ALNY

GuruFocus.com

2 months ago

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference
ALNY

Business Wire

2 months ago

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report
ALNY

Simply Wall St.

2 months ago

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y
ALNY

Zacks

2 months ago

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

ALNY

MT Newswires

2 months ago

UBS Adjusts Alnylam Pharmaceuticals Price Target to $349 From $331, Maintains Buy Rating

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...
ALNY

GuruFocus.com

2 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...

ALNY

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Alnylam Pharmaceuticals Inc Earnings Call

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
ALNY

Zacks

2 months ago

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
ALNY

Zacks

2 months ago

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates

ALNY

MT Newswires

2 months ago

Alnylam Q1 Non-GAAP Net Loss Narrows, Revenue Rises

ALNY

Associated Press Finance

2 months ago

Alnylam: Q1 Earnings Snapshot

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress
ALNY

Business Wire

2 months ago

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations
ALNY

Investor's Business Daily

2 months ago

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
ALNY

Investor's Business Daily

2 months ago

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
ALNY

Zacks

2 months ago

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Receives CHMP Backing For RNAi Therapy Vutrisiran In Europe
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Receives CHMP Backing For RNAi Therapy Vutrisiran In Europe

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
ALNY

Zacks

2 months ago

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline

ALNY

MT Newswires

2 months ago

Alnylam's Transthyretin Amyloidosis Drug Gets Positive Opinion From European Medicines Agency

Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

2 months ago

Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline
ALNY

Zacks

2 months ago

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline

ALNY

MT Newswires

3 months ago

BofA Adjusts Price Target on Alnylam Pharmaceuticals to $328 From $325, Keeps Buy Rating

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
ALNY

Business Wire

3 months ago

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?
ALNY

Insider Monkey

3 months ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?

High Growth Tech Stocks In US With Potential For Expansion
ALNY

Simply Wall St.

3 months ago

High Growth Tech Stocks In US With Potential For Expansion

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs
ALNY

The Wall Street Journal

3 months ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?
ALNY

Zacks

3 months ago

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?

Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy
ALNY

TipRanks

3 months ago

Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?
ALNY

Insider Monkey

3 months ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?

ALNY

Morningstar Research

3 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States
ALNY

Zacks

3 months ago

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference
ALNY

Business Wire

3 months ago

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals' Qfitlia Approved by FDA for Hemophilia A, B Treatment

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip

Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
ALNY

Business Wire

3 months ago

Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025

Sarepta Therapeutics (SRPT) Down 30.3% Since Last Earnings Report: Can It Rebound?
ALNY

Zacks

3 months ago

Sarepta Therapeutics (SRPT) Down 30.3% Since Last Earnings Report: Can It Rebound?

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?
ALNY

Zacks

3 months ago

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
ALNY

Zacks

3 months ago

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?
ALNY

Zacks

3 months ago

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?

ALNY

MT Newswires

3 months ago

JPMorgan Upgrades Alnylam Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $328 From $280

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision

Alnylam price target raised to $338 from $300 at Scotiabank
ALNY

TipRanks

4 months ago

Alnylam price target raised to $338 from $300 at Scotiabank

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
ALNY

Investor's Business Daily

4 months ago

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio

ALNY

MT Newswires

4 months ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug
ALNY

Pharmaceutical Technology

4 months ago

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug

Alnylam Stock Jumps After the FDA Approves Its Heart Drug
ALNY

The Wall Street Journal

4 months ago

Alnylam Stock Jumps After the FDA Approves Its Heart Drug

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
ALNY

Zacks

4 months ago

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?
ALNY

Zacks

4 months ago

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Alnylam Heart Drug Approval Sets Up Challenge With Pfizer
ALNY

Bloomberg

4 months ago

Alnylam Heart Drug Approval Sets Up Challenge With Pfizer

ALNY

MT Newswires

4 months ago

Sector Update: Health Care

ALNY

MT Newswires

4 months ago

RBC Adjusts Price Target on Alnylam Pharmaceuticals to $330 From $310, Maintains Outperform Rating

Share on Social Networks: